Sansh Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.01 M
as on 17-12-2024
- Satisfied Charges ₹ 4.53 Cr
as on 17-12-2024
- Revenue 13.93%
(FY 2020)
- Profit 56.22%
(FY 2020)
- Ebitda 73.15%
(FY 2020)
- Net Worth 102.46%
(FY 2020)
- Total Assets 63.44%
(FY 2020)
About Sansh Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.01 M. The company has closed loans amounting to ₹4.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Chopra and Savina Chopra serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC201247
- Company No.
201247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sansh Biotech Private Limited offer?
Sansh Biotech Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, Respiratory System Drugs, Anti Asthma Drug, Anti Infective Drugs & Medicines, Antibacterial Drugs, Pharma Ingredients & Raw Materials, API Intermediate, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Sansh Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Chopra  | Director | 07-Apr-2010 | Current |
| Savina Chopra | Director | 07-Apr-2010 | Current |
Financial Performance of Sansh Biotech.
Sansh Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.93% increase. The company also saw a substantial improvement in profitability, with a 56.22% increase in profit. The company's net worth Soared by an impressive increase of 102.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sansh Biotech?
In 2020, Sansh Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Feb 2020 | ₹5.01 M | Open |
Others Creation Date: 06 Dec 2021 | ₹9.10 M | Satisfied |
Others Creation Date: 06 Dec 2021 | ₹3.62 Cr | Satisfied |
How Many Employees Work at Sansh Biotech?
Unlock and access historical data on people associated with Sansh Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sansh Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sansh Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
